Bright Minds Biosciences Inc. Common Stock DRUG
$26.20
-52.35%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $147.83
- Implied Upside
- +464.2%
- Price Target Range
- $80.00 – $220.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-15 | Wolfe Research |
Initiates coverage on | Outperform | $150 |
| 2026-08-19 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $145 |
| 2026-08-17 | BTIGThomas Shrader |
Reiterates | Buy | $147 |
| 2026-06-01 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $145 |
| 2026-05-20 | Piper SandlerYasmeen Rahimi |
Maintains | Overweight | $190 → $220 |
| 2026-04-13 | JefferiesAndrew Tsai |
Initiates coverage on | Buy | $145 |
| 2026-03-30 | BTIGThomas Shrader |
Reiterates | Buy | $147 |
| 2026-03-04 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $115 → $145 |
| 2026-02-17 | BTIGThomas Shrader |
Maintains | Buy | $147 |
| 2026-01-07 | BTIGThomas Shrader |
Maintains | Buy | $72 → $147 |
| 2026-01-06 | BTIGThomas Shrader |
Maintains | Buy | $72 → $147 |
| 2026-01-02 | Chardan CapitalRudy Li |
Maintains | Buy | $80 |
| 2025-12-30 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $115 |
| 2025-09-15 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $85 |
| 2025-09-08 | BTIGThomas Shrader |
Initiates coverage on | Buy | $72 |
| 2025-08-19 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $85 |
| 2025-07-02 | Cantor FitzgeraldPete Stavropoulos |
Assumes | Overweight | — |
| 2025-05-21 | Chardan CapitalRudy Li |
Maintains | Buy | $80 |
| 2025-05-13 | TD CowenJoseph Thome |
Initiates coverage on | Buy | — |
| 2025-05-07 | Chardan CapitalRudy Li |
Initiates coverage on | Buy | $80 |
| 2025-02-19 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $85 |
| 2025-01-23 | Piper SandlerYasmeen Rahimi |
Initiates coverage on | Overweight | $93 |
| 2025-01-10 | Cantor FitzgeraldCharles Duncan |
Initiates coverage on | Overweight | — |
| 2025-01-10 | HC Wainwright & Co.Patrick Trucchio |
Initiates coverage on | Buy | $85 |
| 2024-11-25 | BairdJoel Beatty |
Initiates coverage on | Outperform | $75 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $26.20
- Market Cap
- $542.33 million
- 52-Week Range
- $18.90 – $123.75
- Average Volume
- 192K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.